tumor migration inhibition factor

03/01/1985 - "In the present study, it is demonstrated that administration of TMIF can lead to a transient decrease in recoverable tumor cells from the peritoneal cavities of otherwise untreated mice. "
01/01/1985 - "Also, by demonstrating that tumors of human origin are responsive, the present study raises the possibility that studies of TMIF in neoplastic disease may provide information of prognostic value. "
03/01/1986 - "In addition, TMIF-containing preparations can inhibit the binding of tumor cells to endothelial monolayers. "
03/01/1986 - "TMIF can be detected in vivo and can modify the behavior of tumor cells in vivo. "
03/01/1986 - "Both serially passaged animal tumors and spontaneous human neoplasms respond to TMIF. "

09/01/1984 - "Comparative studies utilizing a methylcholanthrene-induced fibrosarcoma as well as solid and ascitic forms of P815 mastocytoma and Ehrlich tumor demonstrate that responsiveness to tumor migration inhibition factor is not merely a property conferred upon tumor cells by prior animal passage in suspension. "

03/01/1986 - "Finally, detection of TMIF or related lymphokines in serum or urine from patients with neoplasms could be useful in the detection of cancer and/or monitoring of occult tumor metastases and tumor recurrence."

09/01/1984 - "Comparative studies utilizing a methylcholanthrene-induced fibrosarcoma as well as solid and ascitic forms of P815 mastocytoma and Ehrlich tumor demonstrate that responsiveness to tumor migration inhibition factor is not merely a property conferred upon tumor cells by prior animal passage in suspension. "